| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/30/2003 | WO2003008556A2 A vector containing an enhanced p15a origin of replication |
| 01/30/2003 | WO2003008555A2 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 01/30/2003 | WO2003008554A2 Methods and compositions for cell therapy |
| 01/30/2003 | WO2003008549A2 Antisense modulation of glioma-associated oncogene-3 expression |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008545A2 Antisense modulation of glioma-associated oncogene-2 expression |
| 01/30/2003 | WO2003008544A2 Antisense modulation of transforming growth factor-beta 3 expression |
| 01/30/2003 | WO2003008543A2 Antisense modulation of bcl2-associated x protein expression |
| 01/30/2003 | WO2003008540A2 Abiotic stress responsive polynucleotides and polypeptides |
| 01/30/2003 | WO2003008539A2 Non-alloying core shell nanoparticles |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008534A2 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof |
| 01/30/2003 | WO2003008455A1 Activity monitor molecules for g-protein trimer |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008451A2 Modification of human variable domains |
| 01/30/2003 | WO2003008450A1 Tumor antigen |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008446A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 01/30/2003 | WO2003008445A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008441A2 Moringa seed proteins |
| 01/30/2003 | WO2003008437A2 Protein and nucleic acid expression systems |
| 01/30/2003 | WO2003008436A2 Methods for the identification of peptidyl compounds interacting with extracellular target molecules |
| 01/30/2003 | WO2003008433A1 Antisense modulation of cd40 ligand expression |
| 01/30/2003 | WO2003008360A1 Method of functionalising solid supports |
| 01/30/2003 | WO2003008074A1 Buffers for electrophoresis and use thereof |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007890A2 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007886A2 Plant ion channels and methods |
| 01/30/2003 | WO2003007884A2 Method and reagents for identifying gene targets for treating breast cancer |
| 01/30/2003 | WO2003007880A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
| 01/30/2003 | WO2003007699A2 Transcription factors of cereals |
| 01/30/2003 | WO2003007698A2 A novel method for the production of transgenic plants |
| 01/30/2003 | WO2003007677A2 Thermal cycling system and method of use |
| 01/30/2003 | WO2003000707A9 Antisense modulation of superoxide dismutase 1, soluble expression |
| 01/30/2003 | WO2002092756A3 Insulin producing cells derived from human embryonic stem cells |
| 01/30/2003 | WO2002090986A9 Colon cancer antigen panel |
| 01/30/2003 | WO2002089817A3 Anti-virus agent |
| 01/30/2003 | WO2002086130A3 Production of genetically modified plants with puroindolines |
| 01/30/2003 | WO2002083837B1 Methods for identifying small molecules that bind specific rna structural motifs |
| 01/30/2003 | WO2002079478A3 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders |
| 01/30/2003 | WO2002077241A3 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002066623A3 Regulation of human phosphatidic acid-preferring phospholipase a1 |
| 01/30/2003 | WO2002060945A3 Human ion channel protein and polynucleotides encoding the same |
| 01/30/2003 | WO2002059332A3 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 01/30/2003 | WO2002058533A3 Process for determining target function and identifying drug leads |
| 01/30/2003 | WO2002053096A3 Single therapy and combination therapy involving drugs with target cellular proteins and drugs which target pathogen-encoded proteins |
| 01/30/2003 | WO2002051355A3 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 01/30/2003 | WO2002050257A3 Method for the production of polyfructans |
| 01/30/2003 | WO2002048382A3 Method for the production of a heterologous protein by a fungus |
| 01/30/2003 | WO2002048333A3 Novel human kinases and uses thereof |
| 01/30/2003 | WO2002048187A3 Secretion signal peptides, their dna sequences, expression vectors for eukaryotic cells that can be produced with the same, and use thereof for biotechnological production of proteins |
| 01/30/2003 | WO2002046366A3 Rf2a and rf2b transcription factors |
| 01/30/2003 | WO2002045523A3 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 01/30/2003 | WO2002044337A3 Wooden leg gene, promoter and uses thereof |
| 01/30/2003 | WO2002042423A3 Antisense modulation of src-2 expression |
| 01/30/2003 | WO2002040502A3 Haplotypes of the lipe gene |
| 01/30/2003 | WO2002036769A3 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 01/30/2003 | WO2002034879A3 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 01/30/2003 | WO2002034772A3 Novel compounds |
| 01/30/2003 | WO2002031150A3 Human ion channel protein and polynucleotides encoding the same |
| 01/30/2003 | WO2002031143A3 Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| 01/30/2003 | WO2002029035A3 Method to alter sugar moieties |
| 01/30/2003 | WO2002029017A3 Nls-tankyrase fusion proteins and their use in screening methods |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002024890A3 Rice mlh1 ortholog and uses thereof |
| 01/30/2003 | WO2002022834A3 Methods of producing cells and animals comprising targeted gene modifications |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/30/2003 | WO2002018567A3 Regulation of human aminotransferase-like enzyme |
| 01/30/2003 | WO2002018566A3 Regulation of human l-asparaginase-like enzyme |
| 01/30/2003 | WO2002017858A3 Role of fosb in bone formation |
| 01/30/2003 | WO2002016603A3 23228, a novel human tetraspanin family member and uses thereof |
| 01/30/2003 | WO2002016588A3 15985, a human serine/threonine protein kinase family membe r and uses thereof |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002016550A3 Antisense rna expression strategies effective against streptococcus thermophilus bacteriophage |
| 01/30/2003 | WO2002014536A3 Odulating multiple lineage kinase proteins |
| 01/30/2003 | WO2002012553A3 Method for detecting mutations in nucleotide sequences |
| 01/30/2003 | WO2002012285A3 The tumor suppressor car-1 |
| 01/30/2003 | WO2002010393A3 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 01/30/2003 | WO2002010362A3 Methods of controlling gene expression and gene silencing |
| 01/30/2003 | WO2002008277A3 Nucleic acids, vectors, host cells, polypeptides, and uses thereof |
| 01/30/2003 | WO2002008245A3 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 01/30/2003 | WO2002007773A3 Multi-component biological transport systems |
| 01/30/2003 | WO2002006322A3 Polycomb genes mez1 and mez2 from maize |
| 01/30/2003 | WO2002004599A3 Placental protein having multiple egf-like domains |
| 01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 01/30/2003 | WO2002002809A3 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2002000719A3 Human and mouse g-protein couipled receptors |
| 01/30/2003 | WO2001094946A3 Microarrays for performing proteomic analyses |
| 01/30/2003 | WO2001094566A3 Human enzymes and polynucleotides encoding the same |